Robert Charles Breedlove, Principal Accounting Officer at Phathom Pharmaceuticals ($PHAT), made three open market sales of company shares over the past year, totaling $26,804. His most recent sale occurred on November 3, 2025. These sales rank 10,884th among 11,678 individual insiders in our database, where the average is $8.6 million across 6.4 transactions per insider. Breedlove recorded no open market purchases in the last 365 days.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 27, 2026 | Phathom Pharmaceuticals, Inc. | $PHAT | Breedlove Robert Charles | Principal Accounting Officer | A | Common Stock | 13000 | $0.00 | 67,013.4000 | 73,396,435 | 24.07% | 0.02% |
| Feb. 27, 2026 | Phathom Pharmaceuticals, Inc. | $PHAT | Breedlove Robert Charles | Principal Accounting Officer | F | Common Stock | 414 | $12.56 | 68,425.4000 | 73,396,435 | 0.60% | 0.00% |
| Feb. 27, 2026 | Phathom Pharmaceuticals, Inc. | $PHAT | Breedlove Robert Charles | Principal Accounting Officer | F | Common Stock | 964 | $12.56 | 68,839.4000 | 73,396,435 | 1.38% | 0.00% |
| Feb. 27, 2026 | Phathom Pharmaceuticals, Inc. | $PHAT | Breedlove Robert Charles | Principal Accounting Officer | A | Common Stock | 2790 | $0.00 | 69,803.4000 | 73,396,435 | 4.16% | 0.00% |
| Jan. 21, 2026 | Phathom Pharmaceuticals, Inc. | $PHAT | Breedlove Robert Charles | Principal Accounting Officer | F | Common Stock | 776 | $13.61 | 54,013.4000 | 73,396,435 | 1.42% | 0.00% |
| Dec. 18, 2025 | Phathom Pharmaceuticals, Inc. | $PHAT | Breedlove Robert Charles | Principal Accounting Officer | F | Common Stock | 230 | $16.28 | 54,789.4000 | 73,396,435 | 0.42% | 0.00% |
| Nov. 3, 2025 | Phathom Pharmaceuticals, Inc. | $PHAT | Breedlove Robert Charles | Principal Accounting Officer | S | Common Stock | 524 | $13.51 | 54,352.4000 | 73,396,435 | 0.95% | 0.00% |
| Sept. 5, 2025 | Phathom Pharmaceuticals, Inc. | $PHAT | Breedlove Robert Charles | Principal Accounting Officer | S | Common Stock | 461 | $12.09 | 54,876.4000 | 63,176,210 | 0.83% | 0.00% |
| July 16, 2025 | Phathom Pharmaceuticals, Inc. | $PHAT | Breedlove Robert Charles | Principal Accounting Officer | S | Common Stock | 1692 | $8.36 | 53,500.4000 | 63,176,210 | 3.07% | 0.00% |
| May 19, 2025 | Phathom Pharmaceuticals, Inc. | $PHAT | Breedlove Robert Charles | Principal Accounting Officer | A | Stock Option (Right to Buy) | 33000 | $0.00 | 33,000.0000 | 63,176,210 | 9999.99% | 0.05% |